Visby Medical Revenue and Competitors

Location

$383.7M

Total Funding

Estimated Revenue & Valuation

  • Visby Medical's estimated annual revenue is currently $35M per year.(i)
  • Visby Medical's estimated revenue per employee is $180,412
  • Visby Medical's total funding is $383.7M.
  • Visby Medical's current valuation is $1.1B. (March 2022)

Employee Data

  • Visby Medical has 194 Employees.(i)
  • Visby Medical grew their employee count by -5% last year.

Visby Medical's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
SVP Quality, Regulatory and Clinical AffairsReveal Email/Phone
3
SVP Research and DevelopmentReveal Email/Phone
4
VP, ITReveal Email/Phone
5
VP FinanceReveal Email/Phone
6
Director Product TransferReveal Email/Phone
7
Director Rewards & Employee ExperienceReveal Email/Phone
8
Chief Medical OfficerReveal Email/Phone
9
Director Marketing, STIReveal Email/Phone
10
Senior Manager Systems EngineeringReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A196%N/AN/A
#2
$7.5M99-1%$38.2MN/A
#3
N/A8100%N/AN/A
#4
N/A148%N/AN/A
#5
N/A525%N/AN/A
#6
$35M194-5%$383.7MN/A
#7
N/A5159%N/AN/A
#8
$15M2538%$100MN/A
Add Company

What Is Visby Medical?

Driven by a belief that results should be quick, accurate, and accessible to all, we are developing a device platform that aims to redefine the way we test and treat illness.

keywords:N/A

$383.7M

Total Funding

194

Number of Employees

$35M

Revenue (est)

-5%

Employee Growth %

$1.1B

Valuation

N/A

Accelerator

Visby Medical News

2022-03-22 - Visby Medical receives funding for at-home Flu-COVID PCR ...

Visby Medical has secured additional funding of $25.5m from the US Biomedical Advanced Research and Development Authority (BARDA) to develop...

2022-03-22 - Visby Medical triggers $25.5M contract option with BARDA to ...

Visby said it designed its developmental-stage flu-COVID-19 PCR test as a single-use, handheld, all-in-one device for detecting and...

2022-03-22 - Visby Medical Executes Contract Option with BARDA for $25.5 ...

Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home...

2021-09-13 - FDA Grants Emergency Use Authorization for Visby Medical's COVID-19 RT-PCR Test for Pooled Samples

SAN JOSE, Calif., Sept. 13, 2021 /PRNewswire/ -- Visby Medical™ announced today that its instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for testing pooled pati ...

2020-10-13 - Visby Medical's Personal PCR Receives Funding from National Institute of Health, RADx Program

SAN JOSE, Calif., Oct. 13, 2020 /PRNewswire/ -- Visby Medical™, an infectious disease diagnostic company, received Phase 2 funding from the National Institutes of Health (NIH) as part of its Rapid Acceleration of Diagnostics (RADx) initiative. The RADx initiative aims to combat SARS-CoV-2 and ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.6M1948%N/A
#2
$73M19426%N/A
#3
$62.3M1948%N/A
#4
$30.4M1953%$17.5M
#5
$38.8M1963%N/A